Ftse Mib
34.492,41
0,13%
DAX
18.497,94
-0,09%
S&P 500
5.277,51
0,80%
NASDAQ
16.735,02
-0,01%
Bitcoin
67.568,92
0,12%
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ SurModics Inc (SRDX) SurModics Inc (SRDX) Notizie

SRDX

SurModics (SRDX)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:SRDX
DataOraFonteTitoloSimboloCompagnia
30/05/202400:36PR Newswire (US)ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Surmodics, Inc.NASDAQ:SRDXSurModics Inc
29/05/202414:04Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:SRDXSurModics Inc
29/05/202413:27Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SRDXSurModics Inc
29/05/202413:00Business WireSurmodics Enters into Definitive Agreement to be Acquired by GTCR for $43.00 Per Share in Cash, Representing an Approximate Equity Value of $627 MillionNASDAQ:SRDXSurModics Inc
24/05/202422:01Edgar (US Regulatory)Form SD - Specialized disclosure reportNASDAQ:SRDXSurModics Inc
01/05/202413:00Business WireSurmodics Reports Second Quarter of Fiscal Year 2024 Financial Results; Updates Fiscal Year 2024 Financial GuidanceNASDAQ:SRDXSurModics Inc
19/04/202413:00Business WireSurmodics to Report Second Quarter of Fiscal 2024 Financial Results on May 1NASDAQ:SRDXSurModics Inc
27/02/202414:00Business WireSurmodics to Participate in Upcoming Investor Conferences in March and AprilNASDAQ:SRDXSurModics Inc
12/02/202422:18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SRDXSurModics Inc
09/02/202417:20Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:SRDXSurModics Inc
01/02/202414:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SRDXSurModics Inc
01/02/202413:00Business WireSurmodics Reports First Quarter of Fiscal Year 2024 Financial Results; Updates Fiscal Year 2024 Financial GuidanceNASDAQ:SRDXSurModics Inc
22/01/202413:30Business WireSurmodics Announces Successful Early Clinical Use of Pounce™ LP (Low Profile) Thrombectomy System, Designed to Address a Critical, Unmet Need by Facilitating Removal of Thrombi and Emboli Below the KneeNASDAQ:SRDXSurModics Inc
16/01/202413:30Business WireSurmodics to Host Virtual Annual Meeting of ShareholdersNASDAQ:SRDXSurModics Inc
16/01/202413:30Business WireSurmodics to Report First Quarter of Fiscal 2024 Financial Results on February 1NASDAQ:SRDXSurModics Inc
18/12/202322:05Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:SRDXSurModics Inc
22/11/202316:22Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:SRDXSurModics Inc
16/11/202313:30Business WireSurmodics Announces 24-Month Data from the SWING Trial Presented at VEITHsymposiumNASDAQ:SRDXSurModics Inc
16/11/202313:30Business WireSurmodics Announces TRANSCEND Trial 36-Month Data Presented at 50th Annual VEITH SymposiumNASDAQ:SRDXSurModics Inc
14/11/202322:05Business WireSurmodics to Participate in the Piper Sandler Healthcare Conference on November 28NASDAQ:SRDXSurModics Inc
08/11/202313:30Business WireSurmodics Reports Fourth Quarter and Fiscal Year 2023 Financial Results; Introduces Fiscal Year 2024 Financial GuidanceNASDAQ:SRDXSurModics Inc
07/11/202313:30Business WireSurmodics Announces TRANSCEND Trial 36-Month Data to be Presented at 50th Annual VEITH SymposiumNASDAQ:SRDXSurModics Inc
07/11/202313:30Business WireSurmodics Announces SWING Trial 24-Month Data to be Presented at VEITH Symposium on November 15NASDAQ:SRDXSurModics Inc
31/10/202312:30Business WireSurmodics Announces Launch of Preside™ Medical Device Coating Technology, Providing Industry-Leading Lubricity and Durability to a Broader Range of Complex Device ApplicationsNASDAQ:SRDXSurModics Inc
10/10/202313:30Business WireSurmodics to Report Fourth Quarter and Fiscal 2023 Financial Results on November 8NASDAQ:SRDXSurModics Inc
09/08/202323:05Business WireSurmodics to Participate in Upcoming Investor Conferences in AugustNASDAQ:SRDXSurModics Inc
02/08/202313:31Business WireSurmodics Reports Third Quarter of Fiscal Year 2023 Financial Results; Updates Fiscal Year 2023 Financial GuidanceNASDAQ:SRDXSurModics Inc
12/07/202313:30Business WireSurmodics to Report Third Quarter of Fiscal 2023 Financial Results on August 2NASDAQ:SRDXSurModics Inc
20/06/202317:10Dow Jones NewsSurmodics Shares Up 8% on FDA Approval for SurVeil Drug-Coated BalloonNASDAQ:SRDXSurModics Inc
20/06/202313:23Dow Jones NewsSurmodics Gets FDA Approval for SurVeil Drug-Coated BalloonNASDAQ:SRDXSurModics Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:SRDX

La tua Cronologia

BIT
UC6THC
Unicredit Bank
BIT
UC5CF4
Unicredit Bank
USOTC
NBLWF
Noble (PK)
ASX
OHE
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network